Literature DB >> 20054819

Dystroglycan is not required for maintenance of the luminal epithelial basement membrane or cell polarity in the mouse prostate.

Alison K Esser1, Michael B Cohen, Michael D Henry.   

Abstract

BACKGROUND: Dystroglycan is a cell-surface receptor for extracellular matrix proteins including laminins and perlecan. Prior studies have shown its involvement in assembly and/or maintenance of basement membrane structures, cell polarity and tissue morphogenesis; and its expression is often reduced in prostate and other cancers. However, the role of dystroglycan in normal epithelial tissues such as the prostate is unclear.
METHODS: To investigate this, we disrupted dystroglycan expression in the prostate via a conditional gene targeting strategy utilizing Cre recombinase expressed in luminal prostate epithelial cells.
RESULTS: Contrary to expectations, deletion of dystroglycan in luminal epithelial cells resulted in no discernable phenotype as judged by histology, basement membrane ultrastructure, localization of dystroglycan ligands, cell polarity or regenerative capacity of the prostate following castration. Dystroglycan expression remains in keratin-5-positive basal cells located in the proximal ducts where dystroglycan expression is elevated in regenerating prostates.
CONCLUSIONS: Our results show that dystroglycan in luminal epithelial cells is not required for the maintenance of basement membranes, cell polarity or prostate regeneration. However, it is possible that persistent dystroglycan expression in the basal cell compartment may support these or other functions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20054819      PMCID: PMC2857647          DOI: 10.1002/pros.21110

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  45 in total

1.  Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation.

Authors:  X Wu; J Wu; J Huang; W C Powell; J Zhang; R J Matusik; F O Sangiorgi; R E Maxson; H M Sucov; P Roy-Burman
Journal:  Mech Dev       Date:  2001-03       Impact factor: 1.882

2.  Reduced expression of dystroglycan in breast and prostate cancer.

Authors:  M D Henry; M B Cohen; K P Campbell
Journal:  Hum Pathol       Date:  2001-08       Impact factor: 3.466

3.  Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration.

Authors:  Ronald D Cohn; Michael D Henry; Daniel E Michele; Rita Barresi; Fumiaki Saito; Steven A Moore; Jason D Flanagan; Mark W Skwarchuk; Michael E Robbins; Jerry R Mendell; Roger A Williamson; Kevin P Campbell
Journal:  Cell       Date:  2002-09-06       Impact factor: 41.582

4.  Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy.

Authors:  Steven A Moore; Fumiaki Saito; Jianguo Chen; Daniel E Michele; Michael D Henry; Albee Messing; Ronald D Cohn; Susan E Ross-Barta; Steve Westra; Roger A Williamson; Toshinori Hoshi; Kevin P Campbell
Journal:  Nature       Date:  2002-07-25       Impact factor: 49.962

5.  Dystroglycan is required for polarizing the epithelial cells and the oocyte in Drosophila.

Authors:  Wu-Min Deng; Martina Schneider; Richard Frock; Casimiro Castillejo-Lopez; Emily Anne Gaman; Stefan Baumgartner; Hannele Ruohola-Baker
Journal:  Development       Date:  2003-01       Impact factor: 6.868

6.  Distinct roles for dystroglycan, beta1 integrin and perlecan in cell surface laminin organization.

Authors:  M D Henry; J S Satz; C Brakebusch; M Costell; E Gustafsson; R Fässler; K P Campbell
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285

7.  A luminal epithelial stem cell that is a cell of origin for prostate cancer.

Authors:  Xi Wang; Marianna Kruithof-de Julio; Kyriakos D Economides; David Walker; Hailong Yu; M Vivienne Halili; Ya-Ping Hu; Sandy M Price; Cory Abate-Shen; Michael M Shen
Journal:  Nature       Date:  2009-09-09       Impact factor: 49.962

8.  Adhesion-dependent tyrosine phosphorylation of (beta)-dystroglycan regulates its interaction with utrophin.

Authors:  M James; A Nuttall; J L Ilsley; K Ottersbach; J M Tinsley; M Sudol; S J Winder
Journal:  J Cell Sci       Date:  2000-05       Impact factor: 5.285

9.  Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis.

Authors:  Akira Tsujimura; Yasuhiro Koikawa; Sarah Salm; Tetsuya Takao; Sandra Coetzee; David Moscatelli; Ellen Shapiro; Herbert Lepor; Tung-Tien Sun; E Lynette Wilson
Journal:  J Cell Biol       Date:  2002-06-24       Impact factor: 10.539

10.  Matrix assembly, regulation, and survival functions of laminin and its receptors in embryonic stem cell differentiation.

Authors:  Shaohua Li; David Harrison; Salvatore Carbonetto; Reinhard Fassler; Neil Smyth; David Edgar; Peter D Yurchenco
Journal:  J Cell Biol       Date:  2002-06-24       Impact factor: 10.539

View more
  5 in total

Review 1.  Integrins and epithelial cell polarity.

Authors:  Jessica L Lee; Charles H Streuli
Journal:  J Cell Sci       Date:  2014-07-02       Impact factor: 5.285

2.  Slow disease progression in a C57BL/6 pten-deficient mouse model of prostate cancer.

Authors:  Robert U Svensson; Jessica M Haverkamp; Daniel R Thedens; Michael B Cohen; Timothy L Ratliff; Michael D Henry
Journal:  Am J Pathol       Date:  2011-05-07       Impact factor: 4.307

3.  The microstructure of laminin-111 compensates for dystroglycan loss in mammary epithelial cells in downstream expression of milk proteins.

Authors:  A J Kent; N Mayer; J L Inman; C Hochman-Mendez; M J Bissell; C Robertson
Journal:  Biomaterials       Date:  2019-07-09       Impact factor: 12.479

4.  Dystroglycan controls signaling of multiple hormones through modulation of STAT5 activity.

Authors:  Dmitri Leonoudakis; Manisha Singh; Roozbeh Mohajer; Pouya Mohajer; Jimmie E Fata; Kevin P Campbell; John L Muschler
Journal:  J Cell Sci       Date:  2010-10-12       Impact factor: 5.285

5.  Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer.

Authors:  Alison K Esser; Michael R Miller; Qin Huang; Melissa M Meier; Daniel Beltran-Valero de Bernabé; Christopher S Stipp; Kevin P Campbell; Charles F Lynch; Brian J Smith; Michael B Cohen; Michael D Henry
Journal:  J Biol Chem       Date:  2012-12-06       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.